Altogether, we demonstrate that specific heterozygous STAT5B germline mutations exert dominant-negative effects resulting in STAT5B deficiency clinically characterized by significant postnatal growth impairment, mild GH insensitivity, eczema, and elevated IgE. The gene discussed is STAT5B; the disease is Eczematoid dermatitis.